Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hydroxychloroquine could still prevent COVID-19 and save tens of thousands of lives around the world, say leading scientific researchers. While it doesn’t work in treatment of hospitalised patients, it could still prevent infections. However, fraudulent data, unjustified extrapolation and exaggerated safety concerns together with intense politicisation and negative publicity may stop COPCOV, the only large, global clinical trial testing hydroxychloroquine in COVID-19 prevention, from ever finding out.

Person using mobile app and screenshot of app interface © MORU 2020. Photographer: Supa-at (Ice) Asarath.
COPCOV participants will use a mobile app to report their health daily.

Engaging youth in health and research in rural Cambodia: a qualitative study.

Journal article

Ean M. et al, (2026), Global health action, 19

Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study

Journal article

Sokulmez-Yildirim S. et al, (2026), International Journal of Infectious Diseases, 169

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis

Journal article

Fadilah I. et al, (2026), The Lancet Regional Health - Western Pacific, 72, 101908 - 101908

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria.

Journal article

Wattanakul T. et al, (2026), CPT: pharmacometrics & systems pharmacology, 15

Ankle brachial index not a reliable tool for risk assessment in people with HIV

Journal article

Trevillyan JM. et al, (2026), HIV Medicine

Load More